Advanced search
Publication Cover
Acta Oncologica Volume 60, 2021 - Issue 1
Journal homepage
1,559
Views
15
CrossRef citations to date
0
Altmetric
Letters to the Editor: Current Challenges; COVID-19

Covid-19 intensive care admissions and mortality among swedish patients with cancer

Gunnar Larforsa Unit of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
,
Simon Pahnkeb Unit of Oncology, Department of Medical Sciences, Uppsala University, Uppsala, SwedenORCID Iconhttps://orcid.org/0000-0002-3541-2027
ORCID Icon,
Maria Statec Department of Analysis, National Board of Health and Welfare, Stockholm, Sweden
,
Katarina Fredrikssonc Department of Analysis, National Board of Health and Welfare, Stockholm, Sweden
&
David Petterssond Department of Registers and Statistics, National Board of Health and Welfare, Stockholm, Sweden
Pages 32-34 | Received 17 Aug 2020, Accepted 17 Nov 2020, Published online: 21 Dec 2020

References

  • Yang K, Sheng Y, Huang C, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–913.
  • Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907–1918.
  • Meng Y, Lu W, Guo E, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1):75.
  • Stroppa EM, Toscani I, Citterio C, et al. Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy). Future Oncol. 2020;16(20):1425–1432.
  • Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935–941.
  • Garassino MC, Whisenant JG, Huang LC, TERAVOLT investigators, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–922.
  • Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893–903.
  • Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395:1919–1926.
  • Lau H, Khosrawipour T, Kocbach P, et al. Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters. Pulmonology. 2020.DOI:10.1016/j.pulmoe.2020.05.015
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
  • WHO. Information note - Covid-19 and NCDs 2020 [updated 23 March 2020]. Available from: https://www.who.int/publications/m/item/covid-19-and-ncds
  • Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
  • Kabarriti R, Brodin NP, Maron MI, et al. Extent of prior lung irradiation and mortality in COVID-19 patients with a cancer history. Adv Radiat Oncol. 2020;5(4):707–710.
  • Shah V, Ko Ko T, Zuckerman M, et al. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience. Br J Haematol. 2020;190(5):e279–e282.
  • Aries JA, Davies JK, Auer RL, et al. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients. Br J Haematol. 2020;190(2):e64–e67.
  • Robilotti EV, Babady NE, Mead PA, et al. Determinants of severity in cancer patients with COVID-19 illness. medRxiv: the preprint server for health sciences; 2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.